Aptus Pharma Share Price
07 Aug, 2026 4:00 PM (IST)
Aptus Pharma Performance
- Today's Low
- ₹280
- Today's High
- ₹280
- 52 Week Low
- ₹32
- 52 Week High
- ₹310
- Open Price₹280
- Previous Close₹286
- Volume2,800
- 50 DMA₹237.30
- 100 DMA₹200.20
- 200 DMA-
Aptus Pharma Chart
Investment Returns
- Over 1 Month + 24.52%
- Over 3 Month + 57.19%
- Over 6 Month + 183.54%
Smart Investing Starts Here Start SIP with Aptus Pharma for Steady Growth!
Aptus Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 103.9
- PEG Ratio
- -
- Market Cap Cr
- 480
- P/B Ratio
- 20.6
- Average True Range
- 10.8
- EPS
- 2.7
- Dividend Yield
- 0
- MACD Signal
- 16.1
- RSI
- 64.6
- MFI
- 84.48
Latest Stock News Updates
Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Saturday, August 8, 2026
- BSE India
- 2 days 21 hours ago
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE India
- 3 weeks ago
Intimation Regarding Credit Rating assigned by CARE Ratings under Reluation 30 of SEBI (LODR) Regulations, 2015.
- BSE India
- 1 month 1 week ago
Aptus Pharma Financials
Aptus Pharma Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 12
- 20 Day
- ₹265.00
- 50 Day
- ₹237.30
- 100 Day
- ₹200.20
- 200 Day
- -
Resistance and Support
- R3 279.80
- R2 279.80
- R1 279.80
- S1 279.80
- S2 279.80
- S3 279.80
Aptus Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-08 | Preferential issue of shares | |
| 2026-06-12 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Evaluate and deliberate upon the proposal for raising of funds. 2. If thought fit, to authorize the Managing Director of the Company. 3. Other business matters. |
| 2026-04-27 | Audited Results | |
| 2026-03-24 | Bonus issue & Others | Inter-alia, to consider 1. Increase in Authorized Share Capital subject to approval of members of the Company. 2. Other business matters. |
| 2025-11-10 | Half Yearly Results |
About Aptus Pharma
Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. View More- NSE Symbol
- APPL
- BSE Symbol
- 544529
- ISIN
- INE15XJ01010
Similar Stocks to Aptus Pharma
Popular Stocks
Aptus Pharma FAQs
Aptus Pharma share price is ₹279 As on 08 August, 2026 | 16:12
The Market Cap of Aptus Pharma is ₹479.9 Cr As on 08 August, 2026 | 16:12
The P/E ratio of Aptus Pharma is 103.9 As on 08 August, 2026 | 16:12
The PB ratio of Aptus Pharma is 20.6 As on 08 August, 2026 | 16:12
The 52 week High & Low of Aptus Pharma is ₹310.2/₹32.3 respectively As on 08 August, 2026 | 16:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.